Why HHS is Right on Rebates

Killing PBM rebates could lower drug prices without hurting R&D

Update: The Trump Administration withdrew this HHS proposal on July 10th, 2019.

Image for post
Image for post

Principal, RA Capital. Serve on boards of 6 biotech companies. Ex-Founder/CEO of Nivien Therapeutics. Writing is my own.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store